• Amarantus Biosciences Inc., of Sunnyvale, Calif., said positive, peer-reviewed efficacy data for the anti-apoptotic therapeutic protein MANF in an animal model of myocardial infarction were published in The Journal of Biological Chemistry by the Glembotski Lab at the San Diego State University's biology department and the SDSU Heart Institute.